Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 3504

Similar articles for PubMed (Select 16632436)

1.

Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.

Valencia Julve J, Alonso Orduña V, Escó Barón R, López-Mata M, Méndez Villamón A.

Clin Transl Oncol. 2006 Jan;8(1):22-30.

PMID:
16632436
2.

Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.

Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):328-34.

PMID:
12738305
3.

Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93.

PMID:
15590179
4.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
5.

Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.

Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):397-404. Epub 2006 Nov 9.

PMID:
17097833
6.

Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.

Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Kusumi F, Hajiro K, Matsusue S, Takeda H.

Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1049-59.

PMID:
9539559
7.

Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience.

Díaz R, Reynes G, Tormo A, de Juan M, Gironés R, Segura A, Aparicio J, Richart P, de la Cueva H, García J.

Clin Transl Oncol. 2009 Dec;11(12):835-41.

PMID:
20045790
8.

Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.

Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):111-22.

PMID:
15337546
9.

A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.

Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA.

Cancer. 2001 Jul 15;92(2):279-86.

PMID:
11466680
10.

Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study.

De Vita F, Di Martino N, Orditura M, Cosenza A, Galizia G, Del Genio A, Catalano G.

Chest. 2002 Oct;122(4):1302-8.

PMID:
12377857
11.

Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.

Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.

Ann Thorac Surg. 2008 Jun;85(6):1930-6; discussion 1936-7. doi: 10.1016/j.athoracsur.2008.01.097.

PMID:
18498797
12.
13.

Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study.

Wright CD, Wain JC, Lynch TJ, Choi NC, Grossbard ML, Carey RW, Moncure AC, Grillo HC, Mathisen DJ.

J Thorac Cardiovasc Surg. 1997 Nov;114(5):811-5; discussion 816.

PMID:
9375611
14.

Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.

Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR, Fu KK.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1172-80.

PMID:
11483326
15.

Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma.

Lew JI, Gooding WE, Ribeiro U Jr, Safatle-Ribeiro AV, Posner MC.

Arch Surg. 2001 Jul;136(7):737-42; discussion 743.

PMID:
11448381
16.

Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus.

Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):425-33.

PMID:
12957254
17.

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H.

J Clin Oncol. 2005 Apr 1;23(10):2310-7. Erratum in: J Clin Oncol. 2006 Jan 20;24(3):531.

18.

Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer.

Zenda S, Hironaka S, Boku N, Yamazaki K, Yasui H, Fukutomi A, Yoshino T, Onozawa Y, Nishimura T.

Dis Esophagus. 2008;21(3):195-200. doi: 10.1111/j.1442-2050.2007.00750.x.

PMID:
18430098
19.

Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer.

Lin CC, Hsu CH, Cheng JC, Wang HP, Lee JM, Yeh KH, Yang CH, Lin JT, Cheng AL, Lee YC.

Ann Oncol. 2007 Jan;18(1):93-8. Epub 2006 Oct 6.

20.

Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus.

Hennequin C, Gayet B, Sauvanet A, Blazy A, Perniceni T, Panis Y, Mal F, Sarfati E, Valleur P, Belghiti J, Fekete F, Maylin C.

Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):657-64.

PMID:
11172946
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk